(2002) -17
Okamoto T, Yamagishi SI, Inagaki Y, Amano S, Koga K, Abe R, Takeuchi M, Ohno S,Å@Yoshimura A, Makita Z. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin. FASEB J.  2002  16:1928-1930.

Kinjyo I, Hanada T, Inagaki-Ohara K, Mori H, Aki D, Ohishi M, Yoshida H, Kubo M, and Yoshimura A SOCS1/JAB Is a Negative Regulator of LPS-Induced Macrophage Activation.Å@Immunity 2002, 17: 583-591

Seki YI, Hayashi K, Matsumoto A, Seki N, Tsukada J, Ransom J, Naka T, Kishimoto T, Yoshimura A, Kubo M. Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation.Proc Natl Acad Sci U S A. 2002, 99; 13003-13008

Okamoto T, Yamagishi S, Inagaki Y, Amano S, Takeuchi M, Kikuchi S, Ohno S, Yoshimura A. Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro. Biochem Biophys Res Commun. 2002 ;297:419-424.

Hanada T and Yoshimura A Regulation of cytokine signaling and inflammation"  Cytokine and Growth Factor Reviews, 2002; 13 : 413-421.

Yoshida T, Hanada T, Tokuhisa T, Kosai K,  Sata M, Kohara M, Yoshimura A
Activation of STAT3 by the Hepatitis C virus core protein leads to cellular transformation J. Exp. Med. 2002 196: 641-653.

Nagai H, Kim Y, Konishi N, Baba M, Kubota T, Yoshimura A, Emi M. Combined hypermethylation and chromosome loss associated with inactivation of SSI-1/SOCS-1/JAB gene in human hepatocellular carcinomas. Cancer Lett. 2002, 186:59-65.

Ben-Yair L, Slaaby R, Herman A, Cohen Y, Biener E, Moran N, Yoshimura A, Whittaker J, De Meyts P, Herman B, Gertler A.    Preparation and expression of biologically active prolactin and growth hormone receptors and suppressor of cytokine signaling proteins 1, 2, 3, and 6 tagged with cyan and yellow fluorescent proteins. Protein Expr Purif. 2002 ;25: 456-464.

Biener E, Maurice S, Sandowski Y, Cohen Y, Gusakowsky EE, Hooghe R, Yoshimura A, Livnah O, Gertler A.    Recombinant human CIS2 (SOCS2) protein: subcloning, expression, purification, and characterization. Protein Expr Purif. 2002; 25:305-312.

Berlato C, Cassatella MA, Kinjyo I, Gatto L, Yoshimura A, Bazzoni F. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation.  J Immunol. 2002;168:6404-6411.

Gasperini S, Crepaldi L, Calzetti F, Gatto L, Berlato C, Bazzoni F, Yoshimura A, Cassatella MA. Interleukin-10 and cAMP-elevating agents cooperate to induce suppressor of cytokine signaling-3 via a protein kinase A-independent signal. Eur Cytokine Netw. 2002 13:47-53.

Hara H, Takeda A, Takeuchi M, Wakeham AC, Itie A, Sasaki M, Mak TW, Yoshimura A, Nomoto K, Yoshida H. The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes. J Immunol. 2002;168:2288-95

Foley HA, Ofori-Acquah SF, Yoshimura A, Critz S, Baliga BS, Pace BS.  Stat3beta Inhibits gamma globin gene expression in erythroid cells. J Biol Chem. 2002; 277:16211-16219.

Tonko-Geymayer S., Goupille O, Tonko M., Soratro C, Yoshimura A, Streuli C., Ziemiecki A., Kofler R, and Soppler W.  Regulation and function of the cytokine inducible SH-2 domain proteins CIS and SOCS3 in mammary epithelial cells Mol. Endocrinol. 2002 ;16:1680-1695

Flodstrom M, Maday A, Balakrishna D, Cleary MM, Yoshimura A and Sarvetnick N; Antiviral defenses expressed by the pancreatic b cell govern the development of type 1 diabetes after Coxsackievirus B4 infection. Nature Immunology 3 : 373-382, 2002.

Hara H, Takeda A, Takeuchi M, Wakeham AC, Itie A, Sasaki M, and Mak TW, Yoshimura A, Nomoto K and Yoshida H; The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes. J Immunol 168 : 2288-95, 2002.

Ohtsuka S, Takaki S, Iseki S, Miyoshi K, Nakagata N, Kataoka Y, Yoshida N, Takatsu K and Yoshimura A; SH2-B is Required for both Male and Female Reproduction. Mol Cell Biol 22 :  3066-3077, 2002.